Abstract | PURPOSE: To evaluate the efficacy of a controlled release dexamethasone delivery system for suppressing inflammation in an ocular burn + desiccating stress (OB+DS) model. METHODS: Nanowafers (NW) loaded with Dexamethasone (Dex, 10 μg) or vehicles (2.5% Methylcellulose; MC) were fabricated using hydrogel template strategy. C57BL/6 mice were subjected to unilateral alkali ocular burn with concomitant desiccating stress for 2 or 5 days and topically treated either with 2 μL of 0.1% Dex or vehicle four times per day and compared with mice that had MC-NW or Dex-NW placed on their corneas. Clinical parameters were evaluated daily. Mice were euthanized after 2 or 5 days. Quantitative PCR evaluated the expression of inflammatory cytokines IL-1β and IL-6 and matrix metalloproteinases ( MMP) in whole cornea lysates. Myeloperoxidase activity (MPO) was measured using a commercial kit in cornea lysates. RESULTS: Both Dex drop and Dex-NW groups had significantly lower corneal opacity scores compared with their vehicles. Both Dex drops and Dex-NW significantly decreased expression of IL-1β, IL-6, and MMP-9 RNA transcripts compared with vehicle drops or wafers 2 and 5 days after the initial lesion. A significant lower number of neutrophils was found in both Dex treatment groups and this was accompanied by decreased MPO activity compared with vehicle controls. CONCLUSIONS: Dex-NW has efficacy equal to Dex drops in preserving corneal clarity and decreasing expression of MMPs and inflammatory cytokines of the corneas of mice subjected to an OB+DS model.
|
Authors | Fang Bian, Crystal S Shin, Changjun Wang, Stephen C Pflugfelder, Ghanashyam Acharya, Cintia S De Paiva |
Journal | Investigative ophthalmology & visual science
(Invest Ophthalmol Vis Sci)
Vol. 57
Issue 7
Pg. 3222-30
(06 01 2016)
ISSN: 1552-5783 [Electronic] United States |
PMID | 27327581
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, N.I.H., Extramural)
|
Chemical References |
- Alkalies
- Delayed-Action Preparations
- Glucocorticoids
- Dexamethasone
|
Topics |
- Alkalies
(toxicity)
- Animals
- Burns, Chemical
(complications, drug therapy, pathology)
- Cornea
(drug effects, pathology)
- Delayed-Action Preparations
- Dexamethasone
(administration & dosage)
- Disease Models, Animal
- Drug Delivery Systems
- Dry Eye Syndromes
(drug therapy, etiology, pathology)
- Eye Burns
(complications, drug therapy, pathology)
- Female
- Glucocorticoids
(administration & dosage)
- Mice
- Mice, Inbred C57BL
- Nanostructures
|